Search research articles
Contact Us
Filters
Showing results (321-330 of 349) with videos related to
Page
of 35
Sort By:
National Science Review
|
June 22, 2026
Self-adaptive hetero-phase superlattices in TaS<sub>2</sub> via layer-resolved 1T-to-1H transformations
Zhenyu Ding, Yihao Wang, Rui Li, et al.
BMC Medicine
|
January 16, 2026
Safety and preliminary efficacy results of IBI389, an anti-Claudin18.2×CD3 bispecific antibody, in patients with solid tumors and gastric or gastro-esophageal tumors: a phase 1 dose escalation and expansion study
Xiaoyu Li, Ruihong Dai, Qi Xu, et al.
Cell Reports. Medicine
|
December 5, 2023
Tumor-immune microenvironment and NRF2 associate with clinical efficacy of PD-1 blockade combined with chemotherapy in lung squamous cell carcinoma
Jianchun Duan, Yun Zhang, Ran Chen, et al.
JCI Insight
|
February 28, 2017
Switching harmful visceral fat to beneficial energy combustion improves metabolic dysfunctions
Xiaoyan Yang, Wenhai Sui, Meng Zhang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 25, 2021
Tislelizumab Plus Chemotherapy as First-Line Treatment for Locally Advanced or Metastatic Nonsquamous NSCLC (RATIONALE 304): A Randomized Phase 3 Trial
Shun Lu, Jie Wang, Yan Yu, et al.
Physiologia Plantarum
|
December 6, 2024
GhCOMT33D modulates melatonin synthesis, impacting plant response to Cd<sup>2+</sup> in cotton via ROS
Menghao Zhang, Xiugui Chen, Ning Wang, et al.
Nature Medicine
|
August 19, 2025
First-line sacituzumab tirumotecan with tagitanlimab in advanced non-small-cell lung cancer: a phase 2 trial
Shaodong Hong, Qiming Wang, Ying Cheng, et al.
BMC Medicine
|
July 6, 2025
Phase 1 trial of HR070803 (an Irinotecan liposome) in combination with 5-fluorouracil, leucovorin, and oxaliplatin for untreated advanced or metastatic pancreatic ductal adenocarcinoma
Qiang Xu, Xue Zhao, Xianze Wang, et al.
Journal of Advanced Research
|
June 17, 2025
GhGLDH35A gene-mediated ROS homeostasis and stomatal movement via the ascorbic acid pathway confers alkaline stress tolerance
Yapeng Fan, Ning Wang, Shuai Wang, et al.
The Lancet. Oncology
|
May 1, 2019
Tucidinostat plus exemestane for postmenopausal patients with advanced, hormone receptor-positive breast cancer (ACE): a randomised, double-blind, placebo-controlled, phase 3 trial
Zefei Jiang, Wei Li, Xichun Hu, et al.
Page
of 35
Search research articles
Search
Showing results (321-330 of 349) with videos related to
Sort By:
Page
of 35
National Science Review
|
June 22, 2026
Self-adaptive hetero-phase superlattices in TaS<sub>2</sub> via layer-resolved 1T-to-1H transformations
Zhenyu Ding, Yihao Wang, Rui Li, et al.
BMC Medicine
|
January 16, 2026
Safety and preliminary efficacy results of IBI389, an anti-Claudin18.2×CD3 bispecific antibody, in patients with solid tumors and gastric or gastro-esophageal tumors: a phase 1 dose escalation and expansion study
Xiaoyu Li, Ruihong Dai, Qi Xu, et al.
Cell Reports. Medicine
|
December 5, 2023
Tumor-immune microenvironment and NRF2 associate with clinical efficacy of PD-1 blockade combined with chemotherapy in lung squamous cell carcinoma
Jianchun Duan, Yun Zhang, Ran Chen, et al.
JCI Insight
|
February 28, 2017
Switching harmful visceral fat to beneficial energy combustion improves metabolic dysfunctions
Xiaoyan Yang, Wenhai Sui, Meng Zhang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 25, 2021
Tislelizumab Plus Chemotherapy as First-Line Treatment for Locally Advanced or Metastatic Nonsquamous NSCLC (RATIONALE 304): A Randomized Phase 3 Trial
Shun Lu, Jie Wang, Yan Yu, et al.
Physiologia Plantarum
|
December 6, 2024
GhCOMT33D modulates melatonin synthesis, impacting plant response to Cd<sup>2+</sup> in cotton via ROS
Menghao Zhang, Xiugui Chen, Ning Wang, et al.
Nature Medicine
|
August 19, 2025
First-line sacituzumab tirumotecan with tagitanlimab in advanced non-small-cell lung cancer: a phase 2 trial
Shaodong Hong, Qiming Wang, Ying Cheng, et al.
BMC Medicine
|
July 6, 2025
Phase 1 trial of HR070803 (an Irinotecan liposome) in combination with 5-fluorouracil, leucovorin, and oxaliplatin for untreated advanced or metastatic pancreatic ductal adenocarcinoma
Qiang Xu, Xue Zhao, Xianze Wang, et al.
Journal of Advanced Research
|
June 17, 2025
GhGLDH35A gene-mediated ROS homeostasis and stomatal movement via the ascorbic acid pathway confers alkaline stress tolerance
Yapeng Fan, Ning Wang, Shuai Wang, et al.
The Lancet. Oncology
|
May 1, 2019
Tucidinostat plus exemestane for postmenopausal patients with advanced, hormone receptor-positive breast cancer (ACE): a randomised, double-blind, placebo-controlled, phase 3 trial
Zefei Jiang, Wei Li, Xichun Hu, et al.
Page
of 35